Valbuena’s team, through examination of pancreatic tissue slides, identified similar pathological changes in pancreatic β cells of both T2DM and alpha-synucleinopathy patients, notably the presence of phosphorylated alpha-synuclein (12). The gene discussed is SNCA; the disease is synucleinopathy.